ICH M13A published [Design Issues]

posted by ElMaestro  – Denmark, 2024-07-31 16:14 (45 d 05:25 ago) – Posting: # 24114
Views: 1,394

Hi Zuzana,

the ICH document was written in a generic fashion, it does not take into consideration specific cases like yours. This fully justifies a deviation from the guidance. It is for that reason that I think EU regulators would suggest to dose as per SmPC and not as per ICH guidance if you ask for scientific advice. So that is what I would lean towards.

Gut feeling only.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,224 posts in 4,878 threads, 1,652 registered users;
42 visitors (0 registered, 42 guests [including 10 identified bots]).
Forum time: 21:40 CEST (Europe/Vienna)

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5